CompletedNCT01947465

Immunogenicity and Safety of Vaccinations in Immunocompromised Persons

Studying Vasculitis

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Zurich
Principal Investigator: Christoph Hatz, Professor
University of Zurich
Intervention: Hepatitis A vaccine and tetanus vaccine(biological)
Enrollment: 645 enrolled
Eligibility: 18 years · All sexes
Timeline: 2013 – 2016

Study locations (10)

University Hospital of Basel, Rheumatology Division, Basel, Basel Town, Switzerland
Swiss Tropical and Public Health Institute, Basel, Basel Town, Switzerland
Cantonal Hospital Aarau, Division of Rheumatology, Aarau, Canton of Aargau, Switzerland
University of Bern, Inselspital, Division of Infectious Diseases and Travel Medicine, Bern, Canton of Bern, Switzerland
University of Bern, Inselspital, Division of Rheumatology, Bern, Canton of Bern, Switzerland
University of Geneva, University Hospitals, Division of Rheumatology, Geneva, Canton of Geneva, Switzerland
University of Geneva, University Hospitals, Service de Médecine Tropicale et Humanitaire, Geneva, Canton of Geneva, Switzerland
Cantonal Hospital St. Gallen, Division of Rheumatology, Sankt Gallen, Canton of St. Gallen, Switzerland
University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Divison of Infectious Diseases, Zurich, Canton of Zurich, Switzerland
University of Zurich, University Hopsital, Divison of Rheumatology, Zurich, Canton of Zurich, Switzerland

Collaborators

University of Basel · Swiss Tropical & Public Health Institute · University of Bern · University Hospital, Geneva · Cantonal Hospital of St. Gallen · Cantonal Hospital of Aarau, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01947465 on ClinicalTrials.gov

Other trials for Vasculitis

Additional recruiting or active studies for the same condition.

See all trials for Vasculitis →

← Back to all trials